Summary:
This government grant, awarded by the National Institutes of Health (NIH), specifically supports small businesses developing innovative medical devices for treating nervous system disorders. It funds activities crucial for translating promising ideas into market-ready solutions, including prototype development, safety testing, and limited clinical studies to secure FDA approval.
Sponsor:
National Institutes of Health (NIH)
Eligibility:
- U.S.-based small businesses defined as per the Small Business Administration (SBA) guidelines.
- Businesses actively developing therapeutic or diagnostic medical devices targeting nervous system disorders.
- Applicants can possess their own device concepts or be collaborating with established manufacturers.
Benefits:
- Non-dilutive funding: Up to $100,000 in direct costs for Phase I, with potential for larger Phase II awards.
- Cooperative research program: Collaborate with NIH program staff for project planning, monitoring, and guidance.
- Expert assistance: Access specialists in regulatory affairs, intellectual property, commercialization, and strategic partnerships.
- Contract research resources: Utilize specialized services for large animal testing, sterilization, biocompatibility assessment, manufacturing, and medical monitoring (if needed).
Deadline:
The next application deadline is February 20, 2024.